Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26607531 | 1.00 | ATM (0.31) | ATMDPP4 | |
| SCHEMBL27156471 | 1.00 | ATM (0.31) | ATMDPP4 | |
| SCHEMBL30985474 | 1.00 | ATM (0.31) | ATMDPP4 | |
| SCHEMBL4102771 | 1.00 | ATM (0.31) | ATMDPP4 | |
| SCHEMBL31527632 | 1.00 | ATM (0.31) | ATMDPP4 | |
| SCHEMBL15145225 | 0.83 | PIK3CA (0.33) | DPP4 | |
| SCHEMBL3298331 | 0.83 | PIK3CA (0.33) | DPP4 | |
| SCHEMBL3298328 | 0.83 | PIK3CA (0.33) | DPP4 | |
| SCHEMBL26112319 | 0.83 | PIK3CA (0.33) | DPP4 | |
| SCHEMBL3511136 | 0.83 | CFD (0.33) | DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4087583-B1 | ARGINASE INHIBITORS AND METHODS OF USE | MERCK SHARP & DOHME LLC (US) | 2026-04-22 | — | — | EP | disclosed |
| WO-2025080589-A1 | PROCESSES FOR PREPARING KRAS INHIBITORS | INCYTE CORPORATION (US) | 2025-04-17 | — | — | WO | disclosed |
| WO-2025080592-A1 | COMBINATION COMPRISING A KRAS G12D INHIBITOR AND AN EGFR INHIBITOR FOR USE IN THE TREATMENT OF CANCER | INCYTE CORPORATION (US) | 2025-04-17 | — | — | WO | disclosed |
| WO-2025080585-A1 | CRYSTALLINE FORMS OF 3-(1-(( 1 R,4R,5S)-2-AZABICYCLO[2.1.1 ]HEXAN-5-YL)-2-(( 1 R,3R,5R)-2-( CYCLOPROPANECARBONYL)-2-AZABICYCLO[3.1.0]HEXAN-3-YL)-7-(2,3-DICHLOROPHENYL)-6-FLUORO-4-METHYL-1 H-PYRROLO[3,2-C]QUINOLIN-8-YL)PROPANENITRILE | INCYTE CORPORATION (US) | 2025-04-17 | — | — | WO | disclosed |
| WO-2025080593-A1 | COMBINATION THERAPY USING A KRAS G12D INHIBITOR AND PD-1 INHIBITOR OR PD-L1 INHIBITOR | INCYTE CORPORATION (US) | 2025-04-17 | — | — | WO | disclosed |
| WO-2023030385-A1 | PYRIMIDINE-FUSED CYCLIC COMPOUND AND PREPARATION METHOD AND USE THEREOF | 劲方医药科技(上海)有限公司 | 2023-03-09 | — | — | WO | disclosed |
| EP-4087583-A1 | ARGINASE INHIBITORS AND METHODS OF USE | Merck Sharp & Dohme LLC (US) | 2022-11-16 | — | — | EP | disclosed |
| WO-2022228568-A1 | PYRIDINO- OR PYRIMIDO-CYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | 劲方医药科技(上海)有限公司 | 2022-11-03 | — | — | WO | disclosed |
| EP-4053117-A1 | ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS | Achillion Pharmaceuticals, Inc. (US) | 2022-09-07 | — | — | EP | disclosed |
| EP-2499115-A1 | HEPATITIS C VIRUS INHIBITORS | Bristol-Myers Squibb Company (US) | 2012-09-19 | — | — | EP | disclosed |
| WO-2011059850-A1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2011-05-19 | — | — | WO | disclosed |